Litcius/Paper detail

The m <sup>6</sup> A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor

Yiren Xiao, Kaushik N. Thakkar, Hongjuan Zhao, James P. Broughton, Yang Li, José A. Seoane, Anh N. Diep, Thomas J. Metzner, Rie von Eyben, David L. Dill, James D. Brooks, Christina Curtis, John T. Leppert, Jiangbin Ye, Donna M. Peehl, Amato J. Giaccia, Subarna Sinha, Erinn B. Rankin

2020Proceedings of the National Academy of Sciences102 citationsDOIOpen Access PDF

Abstract

Significance Here we report a synthetic lethal interaction between the epitranscriptomic modifier FTO and the tumor suppressor VHL. Notably, FTO inhibition reduced the growth of both HIF wild type and HIF-deficient tumors. These findings reveal an epitranscriptomic vulnerability of VHL-deficient cells and identify a potential HIF-independent therapeutic target for ccRCC tumors.

Topics & Concepts

SuppressorDemethylaseRNACancer researchChemistryMolecular biologyBiologyGeneBiochemistryEpigeneticsRNA modifications and cancerCancer-related gene regulationCancer-related molecular mechanisms research
The m <sup>6</sup> A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor | Litcius